Literature DB >> 28188186

NCCN Guidelines Insights: Bone Cancer, Version 2.2017.

J Sybil Biermann1, Warren Chow2, Damon R Reed3, David Lucas4, Douglas R Adkins5, Mark Agulnik6, Robert S Benjamin7, Brian Brigman8, G Thomas Budd9, William T Curry10, Aarati Didwania6, Nicola Fabbri11, Francis J Hornicek10, Joseph B Kuechle12, Dieter Lindskog13, Joel Mayerson14, Sean V McGarry15, Lynn Million16, Carol D Morris17, Sujana Movva18, Richard J O'Donnell19, R Lor Randall20, Peter Rose21, Victor M Santana22, Robert L Satcher7, Herbert Schwartz23, Herrick J Siegel24, Katherine Thornton25, Victor Villalobos26, Mary Anne Bergman27, Jillian L Scavone27.   

Abstract

The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's guideline recommendations for treating Ewing sarcoma. The data underlying these treatment recommendations are also discussed.
Copyright © 2017 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28188186     DOI： 10.6004/jnccn.2017.0017

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  72 in total

1.  CORR Insights®: Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?

Authors:  John H Healey
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

2.  The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.

Authors:  Yusuke Tsuda; Lei Zhang; Paul Meyers; William D Tap; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2020-05-28       Impact factor: 5.006

3.  TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration.

Authors:  P Chen; J Zhou; J Li; Q Zhang; Q Zuo
Journal:  Clin Transl Oncol       Date:  2018-07-30       Impact factor: 3.405

4.  Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.

Authors:  Kehan Song; Jian Song; Kaiyuan Lin; Feiyan Chen; Xiaosheng Ma; Jianyuan Jiang; Feng Li
Journal:  Int Orthop       Date:  2019-05-24       Impact factor: 3.075

5.  Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.

Authors:  Yanchen Chu; Xiaoli Hu; Guangfeng Wang; Zhijie Wang; Yanjin Wang
Journal:  Oncol Lett       Date:  2019-04-01       Impact factor: 2.967

6.  Novel agent DMAMCL suppresses osteosarcoma growth and decreases the stemness of osteosarcoma stem cell.

Authors:  Gen Ba; Zhongyan Hua; Ning Xu; Simeng Zhang; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  Cell Cycle       Date:  2020-05-13       Impact factor: 4.534

7.  Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study.

Authors:  Kehan Song; Xiao Shi; Xin Liang; Hongli Wang; Fei Zou; Feizhou Lu; Xiaosheng Ma; Jianyuan Jiang
Journal:  Int Orthop       Date:  2018-04-21       Impact factor: 3.075

8.  Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.

Authors:  Inga-Marie Schaefer; Jonathan A Fletcher; G Petur Nielsen; Angela R Shih; Marco L Ferrone; Jason L Hornick; Xiaohua Qian
Journal:  Cancer Cytopathol       Date:  2018-05-14       Impact factor: 5.284

9.  The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas.

Authors:  Hiromasa Yamamoto; Kei Namba; Haruchika Yamamoto; Tomohiro Toji; Junichi Soh; Kazuhiko Shien; Ken Suzawa; Takeshi Kurosaki; Shinji Otani; Mikio Okazaki; Seiichiro Sugimoto; Masaomi Yamane; Katsuhito Takahashi; Toshiyuki Kunisada; Takahiro Oto; Shinichi Toyooka
Journal:  Surg Today       Date:  2020-08-03       Impact factor: 2.549

10.  The oncogenic role of REG γ is exerted by activating the Wnt/β-catenin signaling pathway in osteosarcoma.

Authors:  Zhiqiang Yin; Zhibin Peng; Zhichao Wang; Qinggang Meng
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.